ArticleScientific reports2021

Amphiregulin can predict treatment resistance to palliative first-line cetuximab plus FOLFIRI chemotherapy in patients with RAS wild-type metastatic colorectal cancer.

Sang-A Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.